MENU
LFSC
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

LFSC stock forecast, quote, news & analysis

The investment seeks long-term capital appreciation... Show more

Category: #Health
LFSC
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for LFSC with price predictions
Sep 11, 2026

LFSC in downward trend: 10-day moving average moved below 50-day moving average on September 09, 2026

The 10-day moving average for LFSC crossed bearishly below the 50-day moving average on September 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 3 of 3 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LFSC as a result. In 19 of 30 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 63%.

The Moving Average Convergence Divergence Histogram (MACD) for LFSC turned negative on August 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 16 similar instances when the indicator turned negative. In 13 of the 16 cases the stock turned lower in the days that followed. This puts the odds of success at 81%.

LFSC moved below its 50-day moving average on August 28, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LFSC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +0.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where LFSC advanced for three days, in 100 of 110 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

LFSC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 101 of 111 cases where LFSC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Guardant Health (NASDAQ:GH), Sarepta Therapeutics (NASDAQ:SRPT).

Industry description

The investment seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund (“ETF”) and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund’s investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.

Market Cap

The average market capitalization across the F/m Emerald Life Sciences Innovation ETF ETF is 6.62B. The market cap for tickers in the group ranges from 363.33M to 28.26B. INSM holds the highest valuation in this group at 28.26B. The lowest valued company is OFIX at 363.33M.

High and low price notable news

The average weekly price growth across all stocks in the F/m Emerald Life Sciences Innovation ETF ETF was -2%. For the same ETF, the average monthly price growth was -4%, and the average quarterly price growth was 35%. ATEC experienced the highest price growth at 12%, while BHVN experienced the biggest fall at -19%.

Volume

The average weekly volume growth across all stocks in the F/m Emerald Life Sciences Innovation ETF ETF was -15%. For the same stocks of the ETF, the average monthly volume growth was 10% and the average quarterly volume growth was -40%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 73
P/E Growth Rating: 74
Price Growth Rating: 52
SMR Rating: 83
Profit Risk Rating: 76
Seasonality Score: -23 (-100 ... +100)
View a ticker or compare two or three
LFSC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Details
Category
Health
Address
RBB Fund Inc (RBB)400 Bellevue Pkwy Ste 100Wilmington
Phone
N/A
Web
www.S1Fund.com.
LFSC in downward trend: 10-day moving average moved below 50-day moving average on September 09, 2026